Long non-coding RNAs (lncRNAs) are non-coding RNAs longer than 200 nucleotides with dynamic regulatory functions. They interact with a wide range of molecules such as DNA

RNA

and proteins to modulate diverse cellular functions through several mechanisms and

if deregulated

they can lead to cancer development and progression. Recently

it has been described that lncRNAs are susceptible to form gene fusions with mRNAs or other lncRNAs

breaking the paradigm of gene fusions consisting mainly of protein-coding genes. However

their biological significance in the tumor phenotype is still uncertain. Therefore

their recent identification opens a new line of research to study their biological role in tumorigenesis

and their potential as biomarkers with clinical relevance or as therapeutic targets. The present study aimed to review the lncRNA fusions identified so far and to know which of them have been associated with a potential function. We address the current challenges to deepen their study as well as the reasons why they represent a future therapeutic window in cancer.